5Schaefer E J.HMG-CoA reductase inhibitorsfor hypercholesteroLemia.N Engl J Mad,1998.319:122.
6Bonovas S,Sitaras N M.Does pravastatin promote cancer in elderly patients? a meta-analysis.CMAJ,2007,176 (5):649.
7Mo H,Elson C E.Studies of the Isoprenoid mediated Inhibition of Meralonate Syuthesis Applied to Cancer Chemotherapy and Chemopravention.Exp Biol Med,2004,229(6):567.
8Steiner S,Gaflin C L,Lennon J J,et al.Cholesterol biosynthesis regu lation and pro-tein changes in rat liver following treatmentwith fluvastatin.Toxicol Lett,2001,120(1-3):369.
9Deodwania P,Stone PH,Baircy Merz C N,et al.Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease:resultsof the Study Assessing Goals in the Elderly(SAGE).Circulation,2007,115 (6):700.
10Law M,Rudnieka A R.Stutin safety:a systematic review.Am JCardiol,2006,97 (8A):52C.
